The global hyperpigmentation treatment market is expected to be valued at US$ 4.78 Billion in 2023 and is projected to exhibit a compound annual growth rate (CAGR) of 9.5% from 2023 to 2033.
A slight decrease in melanin synthesis outcomes in skin hypopigmentation. Hyperpigmentation disorders can be treated with laser treatment, cosmeceuticals, and chemical peels. The world market for hyperpigmentation is also being impacted by an increase in the incidence of melasma in addition to a comprehensive understanding of hyperpigmentation therapeutic interventions.
The demand for Hyperpigmentation Treatment Market is escalating as a result of a steady stream of fresh product announcements and capital efficiency by substantial prominent stakeholders in studies and development. Furthermore, rising demand for outpatient and microsurgical procedures are expected to generate lucrative opportunities for the Hyperpigmentation Treatment Market throughout the forecast period. Moreover, owing to insufficient reimbursement policies and the expensive demand for cosmetic procedures, the worldwide economy for hyperpigmentation Disorders Treatment may suffer.
Dermabrasion practices, such as increased use of lasers in the diagnosis of pigmentation ailments, and rising cosmetics spending around the world, are predicted to propel market growth. Furthermore, increasing Research and Development expenditure and aggressive strategies employed by leading competitors, including launching new products are driving overall growth. Based on the American Society of Plastic Surgeons, the percentage of dermabrasion cosmetic procedures rose by 109% between 2000 and 2016, from 42,218 in 2000 to 88,182 in 2016.
Since the bulk of cosmetic products isn't really medical necessities, lockdowns imposition across several countries resulted in the shutdown of beauty services and med spas, dermatology clinics, and department shops. Nevertheless, the prevalence of several skin problems such as has expanded during the COVID-19 pandemic. As a result of the COVID-19 pandemic, the market for Microdermabrasion suffered a major decline, which restricted market expansion.
America's industry is predicted to be the second-largest treatment market for hyperpigmentation treatment. This region's market expansion is attributed to increased federal funding and support for the medical industry, along with increased research and advancement. Owing to the greater awareness of hyperpigmentation illnesses, the existence of burgeoning healthcare technology, a large patient population, and elevated healthcare expenditure, Asia-Pacific is expected to lead the global Hyperpigmentation Treatment market. Owing to a poorly developed medical industry, a lack of specialist knowledge and inadequate healthcare facilities, the Middle East and Africa are expected to account for the lowest portion of the worldwide hyperpigmentation treatment market.
Also, offering laser therapy and phototherapy to facilitate the industry's growth over the forecast timeline. Furthermore, manufacturers that treat hyperpigmentation disorders have lucrative contracts due to technological advances in cosmeceuticals and the resulting increase in the utilization of pharmaceuticals in skincare. Considering the aforementioned facts and figures, the market is projected to exhibit a good rate of growth.
| Report Attribute | Details |
|---|---|
| Expected Market Value (2023) | US$ 4.78 Billion |
| Anticipated Forecast Value (2033) | US$ 11.84 Billion |
| Projected Growth Rate (2023 to 2033) | 9.5% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
In terms of disease evidence, melasma had the world's largest market share for hyperpigmentation illnesses in 2021. Because of soaring melasma occurrences and a growing preference for cosmeceutical diagnosis, dermatological service is in high demand. Melasma's prevalence rose sharply in 2020, affecting more than 5.1 million Americans. Melasma incidence among Asian women of reproductive age could reach 32%. Melasma's rising incidence is predicted to emerge as a major important hyperpigmentation disorder treatment industry trend. From 2018 to 2022, sales witnessed significant growth, registering a CAGR of 9.5%.
Conversely, the medical field in both advanced and emerging nations is expanding at a rapid rate, creating a lucrative treatment potential market. Enhanced federal spending on the biomedical and pharmaceutical industries in emerging regions, the development of medical infrastructure, and growing preference for the category of aesthetic clinics and dermatology centres are expected to contribute to market growth over the forecast period.
Cosmeceutical Nanotechnology Advances for Hyperpigmentation Treatment Boost Market Expansion
Scientists have been looking into how nanotechnology can enhance active substance delivery and ingestion to the skin as well as the effectiveness of specific therapeutic drugs. Nanotechnology has emerged as a potential addition to beauty products due to its capacity to strengthen the characteristics of skincare items in general. Nanotechnology has the potency to modify and optimize aspects such as ingestion, texture, active substance safeguards, and overall performance.
Depigmentation active components including hydroquinone, arbutin, kojic acid, azelaic acid, and retinoic acid, along with innovative nanotechnology strategies, could enhance the effectiveness of hyperpigmentation therapeutic interventions. Nanotechnology is a viable solution for topical hydroquinone management to eliminate hyperpigmentation with ample skin permeation and minimal systemic ingestion to lessen hydroquinone's detrimental effects.
Enhanced Use of Cosmeceuticals in Place of Traditional Agents for Skin Care
Cosmeceuticals are rapidly replacing traditional agents. Phytochemicals, or plant-derived substances, are cosmeceuticals that have been demonstrated to have cellular effects in a variety of dermatological disorders. Moreover, cosmeceuticals are frequently prescribed to treat hyperpigmentation. In general, hyperpigmentation disturbances are challenging to treat, necessitating the use of skin-whitening agents like cosmeceuticals.
These restrict major regulatory stages in melanin synthesis and focus on hyperplastic melanocytes. Owing to their maximum adsorption and permeation in the skin, cosmetics are frequently used to treat facial hyperpigmentation illnesses. As a result, Cosmeceuticals for Skin Care are expected to propel market growth.
Principal Consultant
High Costs to Hinder Market Growth
The vulnerability of post-inflammatory hyperpigmentation induced by the application of laser and light-based equipment, along with the dearth of remuneration by insurance firms for skin restoration methods, are predicted to restrict the procedure's use, stifling market growth. Based on the American Society of Plastic Surgeons (ASPS), non-ablative laser therapy cost approximately US$ 1,031, while ablative treatments cost approximately US$ 2,330 per session.
North America dominates the global market for treating hyperpigmentation
North America dominates the global market for curing pigmentation ailments owing to the increasing incidence of pigmentation ailments, the region's advanced healthcare infrastructure, and the existence of major industry players providing post-inflammatory hyperpigmentation patients with effective treatment options. For instance, the American region has the largest pervasiveness of albinism, based on a StatPearls article titled Albinism published in August 2021. (1:36,000). Furthermore, the incidence rate for African Americans is 1: 10,000, in accordance with the same source. The growing incidence of albinism in the nation is expected to boost demand for therapeutic interventions for hyperpigmentation disorders, driving market growth throughout the forecast period.
An increase in the utilization of laser treatment is expected to have an impact on the Asia Pacific market
In 2021, Asia Pacific accounted for around 36% of the worldwide hyperpigmentation disorder services market. During the forecast timeframe, the industry in the region is expected to be extremely profitable.
The region's industry is predicted to be influenced by an increment in the implementation of laser treatment for many skin conditions, a decline in cultural taboos and a boost in affirmation of pigmentation disorder therapeutic interventions, an expansion in the incidence of multiple skin disorders, an increase in awareness about skin rejuvenation, an upgrade in lifestyle, and a higher disposable income.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The microdermabrasion market is expected to grow rapidly
As microdermabrasion has been shown to help treat hyperpigmentation, this procedure's popularity is expected to rise. Many aesthetic practitioners anticipate a significant rise in customer footfall following the pandemic.
Several factors, including a significant increase in video calls and the benefit of subtle recovery at home, are bolstering post-pandemic future growth. During the forecast timeframe, also the crystal microdermabrasion device segment in the USA is expected to grow at a CAGR of 9%. As a result, the microdermabrasion segment is expected to expand significantly.
The skin clinics segment is poised to account for the majority of the international market
The skin clinics segment is predicted to account for the majority of the global hyperpigmentation disorder treatment market over the coming years. The segment is anticipated to expand in the next few years due to an expansion in the number of skin clinics. To satisfy the increasing demands for hyperpigmentation disorder treatment products, manufacturers and distributors of hyperpigmentation cosmeceutical products are enhancing their supply chains.
Key players in the Hyperpigmentation Treatment market are Episciences, Vivier Pharma, La Roche-Posay, Pierre Fabre Dermo Cosmetique, Bayer, Alvogen, Allergen, Obagi Medical Products, SkinCeuticals International, L’Oréal Paris.
| Report Attribute | Details |
|---|---|
| Market Value in 2023 | US$ 4.78 Billion |
| Market Value in 2033 | US$ 11.84 billion |
| Growth Rate | CAGR of 9.5% from 2023 to 2033 |
| Base Year for Estimation | 2023 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in US$ Billion and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
The hyperpigmentation treatment market is valued at US$ 4.78 billion in 2023.
The hyperpigmentation treatment market is projected to attain a value of US$ 11.84 billion by 2033.
Hyperpigmentation treatment adoption is anticipated to surge at a notable 9.5% CAGR through 2033.
North America stands out as a leading region with significant revenue potential in the market.
The microdermabrasion segment dominates the market.
1. Executive Summary | Hyperpigmentation Treatment Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Type, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2023 to 2033 5.3.1. Pharmacological Therapy 5.3.2. Laser Treatment 5.3.3. Chemical Peels and Bleach 5.3.4. Microdermabrasion 5.3.5. Skin Grafting or Plastic Surgery 5.4. Y-o-Y Growth Trend Analysis By Type, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Type, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033 6.3.1. Skin Clinics 6.3.2. Drug and Cosmetic Stores 6.3.3. Hypermarkets and Supermarkets 6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 7.3.1. North America 7.3.2. Latin America 7.3.3. Europe 7.3.4. Asia Pacific 7.3.5. Middle East and Africa (MEA) 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 8.2.1. By Country 8.2.1.1. United States of America 8.2.1.2. Canada 8.2.2. By Type 8.2.3. By Application 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Type 8.3.3. By Application 8.4. Key Takeaways 9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Type 9.2.3. By Application 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Type 9.3.3. By Application 9.4. Key Takeaways 10. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. United Kingdom 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Europe 10.2.2. By Type 10.2.3. By Application 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Type 10.3.3. By Application 10.4. Key Takeaways 11. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. China 11.2.1.2. Japan 11.2.1.3. South Korea 11.2.1.4. Singapore 11.2.1.5. Thailand 11.2.1.6. Indonesia 11.2.1.7. Australia 11.2.1.8. New Zealand 11.2.1.9. Rest of Asia Pacific 11.2.2. By Type 11.2.3. By Application 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Type 11.3.3. By Application 11.4. Key Takeaways 12. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. GCC Countries 12.2.1.2. South Africa 12.2.1.3. Israel 12.2.1.4. Rest of MEA 12.2.2. By Type 12.2.3. By Application 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Type 12.3.3. By Application 12.4. Key Takeaways 13. Key Countries Market Analysis 13.1. United States of America 13.1.1. Pricing Analysis 13.1.2. Market Share Analysis, 2022 13.1.2.1. By Type 13.1.2.2. By Application 13.2. Canada 13.2.1. Pricing Analysis 13.2.2. Market Share Analysis, 2022 13.2.2.1. By Type 13.2.2.2. By Application 13.3. Brazil 13.3.1. Pricing Analysis 13.3.2. Market Share Analysis, 2022 13.3.2.1. By Type 13.3.2.2. By Application 13.4. Mexico 13.4.1. Pricing Analysis 13.4.2. Market Share Analysis, 2022 13.4.2.1. By Type 13.4.2.2. By Application 13.5. Germany 13.5.1. Pricing Analysis 13.5.2. Market Share Analysis, 2022 13.5.2.1. By Type 13.5.2.2. By Application 13.6. United Kingdom 13.6.1. Pricing Analysis 13.6.2. Market Share Analysis, 2022 13.6.2.1. By Type 13.6.2.2. By Application 13.7. France 13.7.1. Pricing Analysis 13.7.2. Market Share Analysis, 2022 13.7.2.1. By Type 13.7.2.2. By Application 13.8. Spain 13.8.1. Pricing Analysis 13.8.2. Market Share Analysis, 2022 13.8.2.1. By Type 13.8.2.2. By Application 13.9. Italy 13.9.1. Pricing Analysis 13.9.2. Market Share Analysis, 2022 13.9.2.1. By Type 13.9.2.2. By Application 13.10. China 13.10.1. Pricing Analysis 13.10.2. Market Share Analysis, 2022 13.10.2.1. By Type 13.10.2.2. By Application 13.11. Japan 13.11.1. Pricing Analysis 13.11.2. Market Share Analysis, 2022 13.11.2.1. By Type 13.11.2.2. By Application 13.12. South Korea 13.12.1. Pricing Analysis 13.12.2. Market Share Analysis, 2022 13.12.2.1. By Type 13.12.2.2. By Application 13.13. Singapore 13.13.1. Pricing Analysis 13.13.2. Market Share Analysis, 2022 13.13.2.1. By Type 13.13.2.2. By Application 13.14. Thailand 13.14.1. Pricing Analysis 13.14.2. Market Share Analysis, 2022 13.14.2.1. By Type 13.14.2.2. By Application 13.15. Indonesia 13.15.1. Pricing Analysis 13.15.2. Market Share Analysis, 2022 13.15.2.1. By Type 13.15.2.2. By Application 13.16. Australia 13.16.1. Pricing Analysis 13.16.2. Market Share Analysis, 2022 13.16.2.1. By Type 13.16.2.2. By Application 13.17. New Zealand 13.17.1. Pricing Analysis 13.17.2. Market Share Analysis, 2022 13.17.2.1. By Type 13.17.2.2. By Application 13.18. GCC Countries 13.18.1. Pricing Analysis 13.18.2. Market Share Analysis, 2022 13.18.2.1. By Type 13.18.2.2. By Application 13.19. South Africa 13.19.1. Pricing Analysis 13.19.2. Market Share Analysis, 2022 13.19.2.1. By Type 13.19.2.2. By Application 13.20. Israel 13.20.1. Pricing Analysis 13.20.2. Market Share Analysis, 2022 13.20.2.1. By Type 13.20.2.2. By Application 14. Market Structure Analysis 14.1. Competition Dashboard 14.2. Competition Benchmarking 14.3. Market Share Analysis of Top Players 14.3.1. By Regional 14.3.2. By Type 14.3.3. By Application 15. Competition Analysis 15.1. Competition Deep Dive 15.1.1. Episciences 15.1.1.1. Overview 15.1.1.2. Product Portfolio 15.1.1.3. Profitability by Market Segments 15.1.1.4. Sales Footprint 15.1.1.5. Strategy Overview 15.1.1.5.1. Marketing Strategy 15.1.2. Vivier Pharma 15.1.2.1. Overview 15.1.2.2. Product Portfolio 15.1.2.3. Profitability by Market Segments 15.1.2.4. Sales Footprint 15.1.2.5. Strategy Overview 15.1.2.5.1. Marketing Strategy 15.1.3. La Roche-Posay 15.1.3.1. Overview 15.1.3.2. Product Portfolio 15.1.3.3. Profitability by Market Segments 15.1.3.4. Sales Footprint 15.1.3.5. Strategy Overview 15.1.3.5.1. Marketing Strategy 15.1.4. Pierre Fabre Dermo Cosmetique 15.1.4.1. Overview 15.1.4.2. Product Portfolio 15.1.4.3. Profitability by Market Segments 15.1.4.4. Sales Footprint 15.1.4.5. Strategy Overview 15.1.4.5.1. Marketing Strategy 15.1.5. Bayer 15.1.5.1. Overview 15.1.5.2. Product Portfolio 15.1.5.3. Profitability by Market Segments 15.1.5.4. Sales Footprint 15.1.5.5. Strategy Overview 15.1.5.5.1. Marketing Strategy 15.1.6. Alvogen 15.1.6.1. Overview 15.1.6.2. Product Portfolio 15.1.6.3. Profitability by Market Segments 15.1.6.4. Sales Footprint 15.1.6.5. Strategy Overview 15.1.6.5.1. Marketing Strategy 15.1.7. Allergen 15.1.7.1. Overview 15.1.7.2. Product Portfolio 15.1.7.3. Profitability by Market Segments 15.1.7.4. Sales Footprint 15.1.7.5. Strategy Overview 15.1.7.5.1. Marketing Strategy 15.1.8. Obagi Medical Products 15.1.8.1. Overview 15.1.8.2. Product Portfolio 15.1.8.3. Profitability by Market Segments 15.1.8.4. Sales Footprint 15.1.8.5. Strategy Overview 15.1.8.5.1. Marketing Strategy 15.1.9. SkinCeuticals International 15.1.9.1. Overview 15.1.9.2. Product Portfolio 15.1.9.3. Profitability by Market Segments 15.1.9.4. Sales Footprint 15.1.9.5. Strategy Overview 15.1.9.5.1. Marketing Strategy 15.1.10. L'oreal Paris 15.1.10.1. Overview 15.1.10.2. Product Portfolio 15.1.10.3. Profitability by Market Segments 15.1.10.4. Sales Footprint 15.1.10.5. Strategy Overview 15.1.10.5.1. Marketing Strategy 16. Assumptions & Acronyms Used 17. Research Methodology
Explore Healthcare Insights
View Reports
Hyperpigmentation Treatment Market
